Alexis Battle is an Associate Professor at Johns Hopkins University with appointments in Biomedical Engineering , Computer Science , and Genetic Medicine (secondary). She directs the Malone Center for Engineering in Healthcare and serves as Deputy Director of the Data Science and AI Institute . Educated at Stanford University (PhD in Computer Science, 2013), Battle transitioned to academia after leadership roles at Google. Research Focus: Battle’s work bridges genomics and machine learning , emphasizing the impact of genetic variation on human health. Her lab develops tools like Watershed to predict functional effects of rare variants, aiming to enhance rare disease diagnosis. Key themes include non-coding DNA analysis , personalized genomics , and systems biology , with applications in cardiovascular disease and neurodegenerative disorders . Publications & Awards: Over 60 peer-reviewed articles in journals like Nature , Science , and Genome Biology , with recent emphasis on single-cell transcriptomics , multiomics integration , and telomere biology . Recipient of the President’s Frontier Award (2022), Microsoft Investigator Fellowship (2019), and Searle Scholar (2016). Scientific Awards: 2022 President’s Frontier Award 2019 Microsoft Investigator Fellowship 2019 Johns Hopkins Discovery Award 2017 Johns Hopkins Catalyst Award 2016 Searle Scholar Advising & Funding: Mentors 11 PhD students, 3 undergraduates, and postdoctoral fellows. Her research is funded by NIH, Searle Scholars, and institutional grants. The Battle Lab collaborates on projects like the GTEx Consortium , focusing on gene regulation and clinical genomics .
Kelly Arnold is an Associate Professor in the Department of Biomedical Engineering at the University of Michigan. Her research integrates systems engineering principles with immunology to investigate variability in immune responses across infection, vaccination, and injury, with a focus on computational modeling and clinical translation. Research Focus Systems-level immune response modeling Vaccination and antibody functionality Vaginal microbiome-host interactions Chronic lung disease progression Computational serology and proteomics Recent Work Her 2025 studies examine SARS-CoV-2 vaccination responses in cancer patients and computational frameworks for vaginal probiotics. Earlier works (2024-2007) span COPD progression, lupus fibrosis, HIV susceptibility, and tissue engineering for fertility preservation. Methodologies include proteomic profiling, network modeling, and microfluidic systems.
John W. van de Lindt is the Harold H. Short Endowed Chair Professor in Civil and Environmental Engineering at Colorado State University and Co-director of the NIST Center of Excellence for Risk-Based Community Resilience Planning. His research develops performance-based engineering frameworks for natural hazards including earthquakes, tsunamis, hurricanes, and tornadoes. Research integrates physical testing (full-scale shake tables), computational modeling, and field reconnaissance to quantify community resilience. Key areas include: multi-hazard fragility assessment; coupled physical-socio-economic recovery modeling; climate adaptation strategies; and resilient timber structural systems. Recent projects include longitudinal tornado impact studies, earthquake-tsunami risk assessment for coastal communities, and life-cycle analysis of sustainable buildings. Publications document innovations in resilience-informed design, validation of recovery models using disaster reconnaissance, and development of the IN-CORE computational platform for community resilience planning. Research consistently bridges structural engineering with social science for multidisciplinary disaster impact reduction. Awards include ASCE Fellow (2019), Ernest E. Howard Award (2017), and multiple best paper awards. Van de Lindt has led disaster reconnaissance following major US events including the 2021 Midwest tornado outbreak.
Professor Guy Williams is a leading academic at the University of Cambridge with a focus on imaging science and clinical neurosciences, affiliated with Downing College and the Wolfson Brain Imaging Centre . Holding a PhD in Physics from his initial Natural Sciences degree, he specializes in nuclear magnetic resonance (NMR) and MRI techniques for brain imaging. Education: BA, PhD in Physics His research centers on non-invasive imaging of brain structure and function, particularly in traumatic brain injury (TBI) and dementia. His work involves developing novel MRI pulse sequences and advanced data analysis algorithms, including AI-based diagnostic tools. He leads studies on white matter integrity post-trauma, longitudinal dementia assessment, and applications of MRI in disorders of consciousness and addiction. Recent publications highlight collaborations in traumatic brain injury outcomes, AI-guided dementia prediction, and neuroimaging of post-COVID cognitive deficits. His team's work on ultra-high field laminar fMRI and distortion correction methods has advanced clinical neuroscience applications. Key techniques include diffusion tensor imaging (DTI), 7 Tesla MRI, and positron emission tomography (PET/MR). His research spans from basic NMR physics to clinical translation, with a strong emphasis on multi-site studies and real-world diagnostic implementation.
Diana Allen is a Professor in the Department of Earth Sciences at Simon Fraser University, where she leads the Groundwater Resources Research Group (GRRG). Her research focuses on hydrogeology with particular emphasis on groundwater resource evaluation and hydrogeological modeling, with current research on climate change impacts on groundwater systems, groundwater resources in mountainous and coastal regions, and low temperature geothermal systems. Education: B.Sc. Honours, Carleton University, 1986 M.Sc., Carleton University, 1988 Ph.D., Carleton University, 1996 Dr. Allen's research spans several key areas of hydrogeology and water resources. Her work on climate change impacts examines how extreme climate events affect groundwater systems, particularly in mountainous regions. She has developed methodologies for reconstructing historical groundwater levels using tree ring widths to understand long-term drought patterns. Her research on coastal aquifers assesses vulnerability to salinization, while her work in Northeast British Columbia evaluates water security risks associated with shale gas development. She also investigates aquifer-stream connectivity and the impacts of pumping on streamflow. Dr. Allen's publication record shows a strong focus on applied hydrogeology with significant contributions to understanding groundwater responses to climate extremes, drought assessment methodologies, and coastal aquifer vulnerability. Her research combines field studies with numerical modeling across diverse environments from mountainous regions to coastal deltas. Dr. Allen has successfully secured funding from major agencies including NSERC, the Canadian Mountain Network, the Pacific Institute for Climate Solutions, and various BC government ministries. Her research has practical applications for water resource management under climate change. As a dedicated educator and mentor, Dr. Allen supervises numerous graduate students working on cutting-edge hydrogeological research projects across British Columbia and beyond. Her students pursue careers in hydrogeology and environmental geoscience, applying GIS methods and computational hydrogeology to analyze field data.
Dr. Jacques Archambault is a Professor in the Department of Microbiology and Immunology at McGill University , and an associate member of the Division of Experimental Medicine since 2016. His research focuses on the molecular biology and pathogenesis of human papillomaviruses (HPVs) and polyomaviruses (HPyVs), with an emphasis on their replication mechanisms as episomes in host cells. The Archambault laboratory employs functional genomics, proteomics, and chemical biology approaches to identify cellular pathways exploited by these viruses and develop high-throughput assays for screening small molecule inhibitors of viral replication. Analysis of his recent publications reveals a strong focus on HPV and HPyV replication machinery, including studies on the E1 helicase, UAF1-USP1 interactions, and structural characterization of viral proteins involved in DNA replication. His work bridges virology, oncology, and drug discovery, particularly targeting oncogenic HPV types implicated in anogenital and oropharyngeal cancers, as well as HPyVs like BKPyV and JCPyV that cause pathologies in immunosuppressed patients. Current efforts in the lab aim to elucidate the molecular mechanisms by which HPVs and HPyVs replicate their genomes and to develop antiviral therapies targeting these processes. Techniques such as fluorescence anisotropy, NMR spectroscopy, and crystallography are frequently employed to study protein-DNA and protein-protein interactions critical to viral replication.
Iona Cheng is a Professor in the Department of Epidemiology and Biostatistics at the University of California, San Francisco (UCSF), where she conducts groundbreaking research in cancer epidemiology. She serves as co-Investigator of the SEER Greater Bay Area Cancer Registry and is Principal Investigator of multiple NIH- and foundation-funded projects examining genetics, lifestyle factors, and neighborhood characteristics in relation to cancer risk. Dr. Cheng has developed an extensive research program focused on racial/ethnic differences in cancer risk and leads population-based cancer surveillance studies that document variations in cancer incidence and mortality patterns across diverse racial and ethnic groups. University of California, Davis, BS, 1990–1994, Physiology Yale University, MPH, 1999–2001, Chronic Disease Epidemiology University of Southern California, PhD, 2001–2005, Epidemiology University of California, San Francisco, Postdoc, 2006–2008, Genetic and Molecular Epidemiology Dr. Cheng's research spans multiple disciplines within cancer epidemiology, with particular emphasis on understanding how environmental exposures, genetic factors, and social determinants interact to influence cancer risk and outcomes across different racial and ethnic populations. Her work frequently examines the impact of air pollution, endocrine-disrupting chemicals, and neighborhood characteristics on cancer development and survival. She has made significant contributions to understanding cancer disparities among Asian American, Native Hawaiian, and Pacific Islander populations, bringing attention to the unique cancer risks and outcomes within these understudied groups. Her research often leverages the Multiethnic Cohort Study, one of the largest prospective studies of cancer incidence and mortality across diverse racial/ethnic populations. Analysis of Dr. Cheng's recent publications reveals a consistent focus on environmental and social determinants of cancer risk across multiple organ sites. Her work demonstrates a sophisticated integration of epidemiological methods with environmental exposure assessment, genetic analysis, and health disparities research. Many of her studies examine the intersection of environmental exposures and racial/ethnic disparities in cancer outcomes, particularly regarding breast cancer, lung cancer, and other malignancies. She has published extensively on the impact of air pollution on cancer risk and survival, as well as the effects of endocrine-disrupting chemicals like bisphenol A, parabens, and phthalates. American Association for Cancer Research Scholar-in-Training Award (2007) National Institutes of Health Loan Repayment Award (2007) National Institutes of Health Loan Repayment Renewal Award (2009) American Association for Cancer Research Faculty Scholar Award (2011) National Institutes of Health Loan Repayment Renewal Award (2011) National Institutes of Health Loan Repayment Renewal Award (2013) American Journal of Epidemiology/Society of Epidemiology Research Top 10 manuscripts (2014) Cancer Prevention Institute of California Mentoring Award (2015) American Society of Human Genetics Top poster As Principal Investigator of multiple NIH-funded projects, Dr. Cheng oversees substantial research grants focused on cancer epidemiology and health disparities. Her work often involves large interdisciplinary collaborations with researchers across multiple institutions, including the Multiethnic Cohort Study which follows over 200,000 participants from diverse racial/ethnic backgrounds. She has demonstrated leadership in mentoring junior researchers, particularly those from underrepresented backgrounds in science, as evidenced by her Cancer Prevention Institute of California Mentoring Award. Her research program integrates data from cancer registries, electronic health records, and geospatial information to provide comprehensive insights into cancer patterns and risk factors. Dr. Cheng's research is closely connected to the UCSF Helen Diller Family Comprehensive Cancer Center and leverages collaborations with Lawrence Berkeley National Laboratory, which provides advanced technological resources for cancer research. Her work benefits from access to extensive cohort data, sophisticated exposure assessment methods, and interdisciplinary expertise in genetics, environmental science, and computational biology available through these institutional partnerships. She frequently collaborates with researchers studying the genetic and environmental determinants of cancer across multiple organ systems, contributing to a more comprehensive understanding of cancer etiology and prevention strategies.
Maria Timofeeva is an Associate Professor in the Epidemiology, Biostatistics and Biodemography (EBB) department at the University of Southern Denmark (SDU), with additional affiliation at the Danish Institute for Advanced Study (DIAS). She holds an Honorary Fellow position at the University of Edinburgh since December 2019. Her research focuses on cancer prevention and prediction, particularly studying the effects of environmental and genetic factors on cancer risk and progression. Dr. Timofeeva earned her Dr.sc.hum in Epidemiology from Heidelberg University (2005-2009), with a dissertation on genetic polymorphisms as risk factors for early onset lung cancer. Prior to her current position, she worked as a Statistical Geneticist at the University of Edinburgh (2013-2019) and as a Postdoctoral Fellow at the International Agency for Research on Cancer (2009-2013). Her research interests center around understanding the genetics of cancer risk through multi-omic analysis. She leads several significant projects, including the Interdisciplinary Project on Adherence to Colorectal Cancer Screening, meta-analysis of factors associated with false-positive and false-negative FOBT results (registered in PROSPERO ID: CRD42022315767), and the COlorectal Cancer screening Among RElatives (CoCARE) twin-family study in Denmark. Her methodological expertise spans observational epidemiological studies (case-control, population-based cohort studies, twin studies), meta-analysis, umbrella reviews, and multi-omics data analysis. Analysis of her recent publications reveals a strong focus on colorectal cancer genetics, with particular emphasis on genome-wide association studies, Mendelian randomization approaches, and trans-ancestry analyses. Her work frequently leverages large datasets including the UK Biobank and international consortia, with applications in cancer risk prediction and understanding gene-environment interactions. Dr. Timofeeva has an extensive publication record with 73 publications listed in her profile. Her research has been cited across multiple platforms, with mentions in news outlets, social media, and academic readership platforms like Mendeley. She is actively involved in academic service, serving as a peer reviewer for journals including BMC Cancer and Scientific Reports, and participating in conferences such as the 26th Nordic Congress of Gerontology. She also serves on evaluation committees, including with the World Cancer Research Fund International (April-May 2024). Her teaching activities include courses on evidence-based drug utilization and biostatistics, as well as supervision of research projects on gene expression in twins. Dr. Timofeeva has engaged with the public through media contributions, including an interview titled 'Jeg vil forstå, hvorfor vi får kræft' (November 15, 2021), where she discussed understanding why we get cancer.
Olivia Di Matteo serves as an Assistant Professor in the Department of Electrical and Computer Engineering within UBC's Faculty of Applied Science, leading the Quantum Software and Algorithms Research (QSAR) group since her January 2022 appointment. Her academic foundation includes a BSc from Lakehead University and MSc/PhD in Physics (Quantum Information) from the University of Waterloo, completed in 2019. Dr. Di Matteo's research centers on quantum software engineering , with pioneering work in quantum compilation , circuit optimization , and debugging tools . She champions open-source quantum frameworks and develops accessible educational resources to democratize quantum computing. Analysis of her 15 most recent publications (2021-2025) reveals dominant trends in quantum programming infrastructure, particularly circuit analysis (33%), bug classification (20%), and qubit network optimization (15%), with strong emphasis on practical software tooling over theoretical physics. No scientific awards were documented in the source materials. She advises graduate students in the QSAR group while contributing to open-source quantum ecosystems through projects like PennyLane and The Ionizer transpiler, and teaches courses including CPEN 400Q (Gate-model quantum computing) and ELEC 221 (Signals and Systems). The QSAR group operates at the intersection of quantum software development and education, focusing on making quantum programming accessible through visual tools, real-time debugging environments, and hardware-agnostic compilation techniques.
Lindsey Kent is a Professor at the University of St Andrews' School of Medicine, where she serves as Deputy Head and Director of Admissions. Her research focuses on the biological foundations of psychiatric disorders, particularly ADHD and developmental language disorders. Education: Medicine (Aberdeen University, 1989), PhD (University of Birmingham, 1998) Academic Appointments: Wellcome Trust Fellow (1999), University Lecturer (University of Cambridge, 2003), Reader (University of St Andrews, 2007) Research Trends: Dr. Kent's work explores psychiatric genetics, neurodevelopmental disorders, and molecular mechanisms through genome-wide association studies, exome sequencing, and genetic epidemiology. Key Collaborations: Psychiatric Genomics Consortium, EAGLE Consortium, 23andMe Technical Focus: ATP2C2 gene variants, TNR gene associations, polygenic risk architectures Awards: Fellow of the Higher Education Academy (2000) Academic Contributions: She has directed two Wellcome Trust-funded projects on ADHD genetics and co-authored over 91 peer-reviewed publications, including significant studies in Nature Communications and Human Molecular Genetics . Her editorial roles include serving on the American Journal of Medical Genetics board (2007–2014).
Prof. Dr. Urs F. Greber is an Ordinary Professor of Molecular Cell Biology at the Department of Molecular Life Sciences, Faculty of Mathematics and Natural Sciences, University of Zurich. His research focuses on understanding how viruses interact with host cells, particularly adenoviruses and rhinoviruses that cause human respiratory diseases. He leads the Greber Lab, which investigates viral entry mechanisms, replication processes, and the cellular responses to infection. Greber's research interests span virology, molecular cell biology, and infection mechanisms. His lab explores how viruses take control over membrane and lipid functions, cytoplasmic transport processes, and cellular metabolism to support their gene expression and progeny formation. They employ system-wide profiling, molecular cell biology approaches, light microscopy, and machine learning for image analysis to map the cell state underlying viral infections of cultured and primary human cells, including lung organoids and iPSC-derived macrophages. A key focus is understanding cell-to-cell variability in infection phenotypes and the mode-of-action of antiviral compounds. The Greber Lab has published extensively on adenovirus biology, including viral entry, uncoating, nuclear import, and assembly mechanisms. Their recent work has identified broad-spectrum antiviral compounds, elucidated alternative virus entry pathways, and developed innovative imaging and AI-based approaches for quantifying virus infectivity. Their research contributes to understanding how viruses break down host defense barriers and has implications for antiviral therapy development. Greber has supervised numerous PhD and Master's students including Cornelia Bircher, Alessandro Savi, Franziska Tomas, Alfonso Gomez-Gonzalez, Anthony Petkidis, and Dominik Olszewski. His lab has received funding from the Swiss National Science Foundation, including a grant for coronavirus research during the pandemic. The lab actively collaborates with other research groups at University of Zurich, ETH Zurich, and international institutions. Current projects include exploring how viral DNA interactions contribute to infection outcome variability, investigating adenovirus egress mechanisms, and developing high-throughput screening methods for antiviral compounds.
Regina Ragan is a Professor in the Department of Materials Science and Engineering at the Samueli School of Engineering, University of California, Irvine. Her research focuses on nanomaterials, self-assembly, and surface-enhanced Raman scattering (SERS) for applications in optical communication, energy systems, and biomedical diagnostics. Education: Ph.D. in Applied Physics, California Institute of Technology, 2002 M.S. in Applied Physics, California Institute of Technology, 1998 B.S. in Materials Science and Engineering, University of California, Los Angeles, 1996 Her work integrates scanning probe microscopy and first-principles calculations to study thermodynamic driving forces in self-assembly and structure-function relationships. Recent publications highlight applications in antimicrobial susceptibility testing, environmental monitoring, and plasmonic device fabrication. The Ragan group develops low-cost diagnostic tools using SERS for telemedicine applications. Current lab members include graduate students and postdoctoral researchers working on nanoscale systems from atomic to mesoscale. Scientific Awards: NSF CAREER Award for fundamental studies of biological/inorganic interfaces Research Trends: Recent articles show a focus on SERS-based diagnostics, plasmonic nanoantennas, machine learning-assisted spectral analysis, and scalable synthesis of 3D graphene architectures. Subfields span quantum plasmonics, stress-activated materials, and biofilm monitoring.
Hyuck Jin Park is a Full Professor in the Department of Energy Resources and Geosystems Engineering at Sejong University, South Korea, where he has been teaching and conducting research since 2003. With a Ph.D. in Engineering Geology from Purdue University, his expertise spans geotechnical engineering, landslide analysis, and geospatial technologies. Professor Park has built a distinguished career in landslide hazard assessment, combining traditional geotechnical approaches with modern machine learning techniques to improve prediction accuracy and risk management. His educational background includes: B.S. in Geology from Yonsei University (1990) M.S. in Geophysics from Yonsei University (1993) Ph.D. in Engineering Geology from Purdue University (2011) Professor Park's research focuses on the spatial and temporal probability of landslide occurrence, utilizing fuzzy logic, probabilistic analysis, GIS, Monte Carlo simulation, and machine learning for landslide hazard assessment. His work integrates physically based models with statistical approaches to better understand landslide mechanisms and improve prediction capabilities. He has made significant contributions to the development of methodologies that account for geological uncertainties in hazard assessment, with applications ranging from rock slope stability to rainfall-induced shallow landslides. His recent publications demonstrate a clear trend toward integrating explainable artificial intelligence with traditional geotechnical approaches for natural hazard assessment. Professor Park's work increasingly focuses on making machine learning models transparent and interpretable while maintaining high predictive accuracy. The research spans multiple hazard types including landslides, earthquakes, and floods, with a growing emphasis on climate change impacts and data-scarce environments. With an h-index of 28 and over 3,421 citations, Professor Park has established himself as a leading researcher in his field. His work has been published in high-impact journals including Engineering Geology, Landslides, and Catena, reflecting the significance and quality of his contributions to geotechnical engineering and natural hazard assessment. Professor Park has mentored numerous researchers through collaborative projects and has secured funding for his innovative work in landslide prediction and hazard assessment. His research has involved significant international collaboration, particularly with researchers from Malaysia, Australia, and Yemen, addressing landslide and flood risks in diverse geographical contexts. He leads research activities within the Department of Geoinformation Engineering at Sejong University and has contributed to the development of specialized tools like DEWS (Distance, Elevation, Watershed, and Slope unit) for landslide early warning systems.
Deqiong Ma is an Assistant Professor in the Department of Genetics at Yale University School of Medicine and Associate Director of the DNA Diagnostic Laboratory. She holds an MD from Tongji Medical University (1991), a PhD from the University of Tasmania (2003), and completed a postdoctoral fellowship at Duke University and a clinical fellowship at Albert Einstein College of Medicine. Her research focuses on genetic and genomic mechanisms underlying autism spectrum disorders, particularly copy number variants (CNVs), structural variation analysis, and clinical diagnostic methodologies. Key research interests include identifying novel genetic risk factors for autism using advanced genomic techniques, such as homozygosity mapping and fine-scale structural variation analysis. Her work bridges clinical genetics and molecular biology, with applications in diagnostic testing and understanding neurodevelopmental disorders. She collaborates extensively on studies involving autism candidate genes (e.g., MBD5, TBL1X) and genomic pathway analysis. Publications emphasize translational research, including diagnostic improvements for pediatric patients and elucidating genetic architecture in autism. She leads efforts in the DNA Diagnostic Lab to integrate genomic data into clinical practice, focusing on regions of homozygosity and uniparental disomy.
Hongfu Sun is a Senior Lecturer at the School of Engineering, University of Newcastle. His research focuses on innovating MRI mechanisms for clinical and research applications, particularly in Quantitative Susceptibility Mapping (QSM). He is internationally recognized as a pioneer in QSM and integrates MR physics, signal processing, and AI for medical imaging advancements. Sun holds a Ph.D. in Biomedical Engineering from the University of Alberta, Canada. Professional Experience: Senior Lecturer at University of Newcastle (current) ARC DECRA Research Fellow at University of Queensland (2021–2023) Postdoctoral Researcher at University of Calgary (2015–2019) Research Interests: Focuses on MRI innovation, including QSM, deep learning for medical imaging, and AI-driven reconstruction techniques. His work addresses challenges like sub-millimeter resolution and artifact reduction in MRI. Recent projects involve generative AI models for MRI analysis and accelerated quantitative imaging methods. Grants and Funding: AU$1.69M in grants, including a 2021 ARC DECRA for microscopic MRI techniques 2024 NHMRC grant for Parkinson’s disease MRI diagnostics Teaching: Course coordinator for Medical Imaging and Signal Processing at University of Newcastle Focus on biomedical imaging, computational methods, and signal analysis Labs/Teams: Leads research in MRI innovation, collaborating on QSM, deep learning applications, and translational imaging techniques. Active in interdisciplinary projects combining physics, AI, and clinical medicine.
